| |
| |
|
| Insider
Information: |
Reynolds Francis |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
9,045,920 |
|
|
Indirect Shares
|
23,488 |
|
|
| Direct
Value |
$3,602,809 |
|
|
|
Indirect Value
|
$9,355 |
|
|
| Total
Shares |
9,069,408 |
|
|
| Total
Value |
$3,612,164 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Invivo Therapeutics Holdings Cor... |
NVIV |
10% Owner |
2014-05-09 |
9,045,920 |
2014-05-09 |
23,488 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
360 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-03-19 |
4 |
AS |
$2.38 |
$10,115 |
D/D |
(4,250) |
13,508,310 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-03-20 |
4 |
AS |
$2.40 |
$10,200 |
D/D |
(4,250) |
13,504,060 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-03-21 |
4 |
AS |
$2.44 |
$10,370 |
D/D |
(4,250) |
13,499,810 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-03-22 |
4 |
AS |
$2.48 |
$10,540 |
D/D |
(4,250) |
13,495,560 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-03-25 |
4 |
AS |
$2.44 |
$10,370 |
D/D |
(4,250) |
13,491,310 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-03-26 |
4 |
AS |
$2.44 |
$10,370 |
D/D |
(4,250) |
13,487,060 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-03-27 |
4 |
AS |
$2.46 |
$10,455 |
D/D |
(4,250) |
13,482,810 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-03-28 |
4 |
AS |
$2.40 |
$10,200 |
D/D |
(4,250) |
13,478,560 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-04-01 |
4 |
AS |
$2.27 |
$9,648 |
D/D |
(4,250) |
13,474,310 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-04-02 |
4 |
AS |
$2.27 |
$9,648 |
D/D |
(4,250) |
13,470,060 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-04-03 |
4 |
AS |
$2.28 |
$9,690 |
D/D |
(4,250) |
13,465,810 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-04-04 |
4 |
AS |
$2.71 |
$11,518 |
D/D |
(4,250) |
13,461,560 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-04-05 |
4 |
AS |
$2.82 |
$11,985 |
D/D |
(4,250) |
13,457,310 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-04-08 |
4 |
AS |
$2.93 |
$12,453 |
D/D |
(4,250) |
13,453,060 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-04-09 |
4 |
AS |
$3.12 |
$13,260 |
D/D |
(4,250) |
13,448,810 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-04-10 |
4 |
AS |
$3.03 |
$12,878 |
D/D |
(4,250) |
13,444,560 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-04-11 |
4 |
AS |
$3.12 |
$13,260 |
D/D |
(4,250) |
13,440,310 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-04-12 |
4 |
AS |
$3.20 |
$13,600 |
D/D |
(4,250) |
13,436,060 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-04-15 |
4 |
AS |
$3.27 |
$13,898 |
D/D |
(4,250) |
13,431,810 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-04-16 |
4 |
AS |
$3.18 |
$13,515 |
D/D |
(4,250) |
13,427,560 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-04-17 |
4 |
AS |
$3.27 |
$13,898 |
D/D |
(4,250) |
13,423,310 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-04-18 |
4 |
AS |
$3.15 |
$13,388 |
D/D |
(4,250) |
13,419,060 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-04-19 |
4 |
AS |
$3.14 |
$13,345 |
D/D |
(4,250) |
13,414,810 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-04-22 |
4 |
AS |
$3.12 |
$13,260 |
D/D |
(4,250) |
13,410,560 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-04-23 |
4 |
AS |
$2.98 |
$12,665 |
D/D |
(4,250) |
13,406,310 |
0 |
- |
|
360 Records found
|
|
Page 4 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
